Detalhe da pesquisa
1.
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Nat Immunol;
21(11): 1346-1358, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32868929
2.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
N Engl J Med;
389(6): 491-503, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37272513
3.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med;
389(2): 137-147, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37272535
4.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Cancer Sci;
115(2): 540-554, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38098261
5.
Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer.
Jpn J Clin Oncol;
54(4): 479-488, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38183216
6.
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
Int J Clin Oncol;
29(3): 248-257, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38319510
7.
Long-term outcomes of 5-year survivors without recurrence after the complete resection of non-small cell lung cancer after lobectomy: a landmark analysis in consideration of competing risks.
Surg Today;
2024 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38430378
8.
Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectum.
Cancer Sci;
114(5): 2169-2177, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36369892
9.
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinoma.
Cancer Sci;
114(8): 3423-3432, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37264761
10.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet;
399(10335): 1607-1617, 2022 04 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35461558
11.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
N Engl J Med;
383(18): 1711-1723, 2020 10 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32955177
12.
HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
Gastroenterology;
162(3): 799-812, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34687740
13.
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.
Cancer Immunol Immunother;
72(7): 2205-2215, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36862151
14.
Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung Adenocarcinoma.
Mod Pathol;
36(9): 100209, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37149221
15.
Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial.
BMC Cancer;
23(1): 401, 2023 May 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37142953
16.
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503.
Qual Life Res;
32(9): 2629-2637, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37126140
17.
The prognostic impact of a high number of peritumoral alveolar macrophages in neuroendocrine carcinoma in the lung.
Pathol Int;
73(10): 497-508, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37589431
18.
Tumor size exceeding 5 cm as a valid prognostic factor in all stages of thymic epithelial tumors.
Surg Today;
53(1): 42-50, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35908101
19.
Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide database.
Surg Today;
53(11): 1247-1259, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37460670
20.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol;
23(10): 1274-1286, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36108662